Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Knudson, 1971, Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA, 68, 820, 10.1073/pnas.68.4.820 Hung, 2004, Fruit and vegetable intake and risk of major chronic disease, J. Natl. Cancer Inst., 96, 1577, 10.1093/jnci/djh296 Smith-Warner, 2001, Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies, JAMA, 285, 769, 10.1001/jama.285.6.769 van Gils, 2005, Consumption of vegetables and fruits and risk of breast cancer, JAMA, 293, 183, 10.1001/jama.293.2.183 Feskanich, 2000, Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women, J. Natl. Cancer Inst., 92, 1812, 10.1093/jnci/92.22.1812 Zeegers, 2001, Consumption of vegetables and fruits and urothelial cancer incidence: a prospective study, Cancer Epidemiol. Biomarkers Prev., 10, 1121 Zhang, 2000, Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin’s lymphoma among women, Cancer Epidemiol. Biomarkers Prev., 9, 477 Terry, 2001, Fruit, vegetables, dietary fiber, and risk of colorectal cancer, J. Natl. Cancer Inst., 93, 525, 10.1093/jnci/93.7.525 Larsson, 2006, Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study, Cancer Epidemiol. Biomarkers Prev., 15, 301, 10.1158/1055-9965.EPI-05-0696 Michaud, 1999, Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort, J. Natl. Cancer Inst., 91, 605, 10.1093/jnci/91.7.605 Rashidkhani, 2005, Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women, Int. J. Cancer, 113, 451, 10.1002/ijc.20577 Kristal, 2002, Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence, Nutr. Cancer, 42, 1, 10.1207/S15327914NC421_1 Murillo, 2001, Cruciferous vegetables and cancer prevention, Nutr. Cancer, 41, 17, 10.1080/01635581.2001.9680607 Giovannucci, 2003, A prospective study of cruciferous vegetables and prostate cancer, Cancer Epidemiol. Biomarkers Prev., 12, 1403 Newman, 2003, Natural products as sources of new drugs over the period 1981–2002, J. Nat. Prod., 66, 1022, 10.1021/np030096l Butler, 2004, The role of natural product chemistry in drug discovery, J. Nat. Prod., 67, 2141, 10.1021/np040106y Koehn, 2005, The evolving role of natural products in drug discovery, Nat. Rev. Drug Discov., 4, 206, 10.1038/nrd1657 Broadbent, 1998, The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole [Part II], Curr. Med. Chem., 5, 469 Preobrazhenskaya, 1993, Ascorbigen and other indole-derived compounds from Brassica vegetables and their analogs as anticarcinogenic and immunomodulating agents, Pharmacol. Therap., 60, 301, 10.1016/0163-7258(93)90012-3 Safe, 1996, Dietary indoles with antiestrogenic activity in common vegetables and their implications, 73 Verhoeven, 1997, A review of mechanisms underlying anticarcinogenicity by brassica vegetables, Chem. Biol. Interact., 103, 79, 10.1016/S0009-2797(96)03745-3 Aggarwal, 2005, Molecular targets and anticancer potential of indole-3-carbinol and its derivatives, Cell Cycle, 4, 1201, 10.4161/cc.4.9.1993 Bjeldanes, 1991, Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo – comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Proc. Natl. Acad. Sci. USA, 88, 9543, 10.1073/pnas.88.21.9543 Grose, 1992, Oligomerization of indole-3-carbinol in aqueous acid, Chem. Res. Toxicol., 5, 188, 10.1021/tx00026a007 Anderton, 2004, Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice, Clin. Cancer Res., 10, 5233, 10.1158/1078-0432.CCR-04-0163 Wattenberg, 1978, Inhibition of polycyclic hydrocarbon-induced neoplasia by naturally occurring indoles, Cancer Res., 38, 1410 Bradlow, 1991, Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice, Carcinogenesis, 12, 1571, 10.1093/carcin/12.9.1571 Morse, 1990, Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice, Cancer Res., 50, 1613 Tanaka, 1992, Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis, Jpn. J. Cancer Res., 83, 835, 10.1111/j.1349-7006.1992.tb01988.x Tanaka, 1990, Inhibitory effect of sinigrin and indole-3-carbinol in diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats, Carcinogenesis, 11, 1403, 10.1093/carcin/11.8.1403 Grubbs, 1995, Chemoprevention of chemically induced mammary carcinogenesis by indole-3-carbinol, Anticancer Res., 15, 709 Kim, 1994, Biphasic modifying effect on indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague–Dawley rats, Jpn. J. Cancer Res., 85, 578, 10.1111/j.1349-7006.1994.tb02399.x Kojima, 1994, Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indol-3-carbinol, Cancer Res., 54, 1446 Jin, 1999, Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice, Cancer Res., 59, 3991 Oganesian, 1997, Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model, Cancer Lett., 118, 87, 10.1016/S0304-3835(97)00235-8 Blum, 2001, beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol, Carcinogenesis, 22, 315, 10.1093/carcin/22.2.315 Michnovicz, 1990, Induction of estradiol metabolism by dietary indole-3-carbinol in humans, J. Natl. Cancer Inst., 82, 947, 10.1093/jnci/82.11.947 Wortelboer, 1992, Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes, Biochem. Pharmacol., 43, 1439, 10.1016/0006-2952(92)90200-3 Niwa, 1994, Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds, Steroids, 59, 523, 10.1016/0039-128X(94)90070-1 Jellinck, 1991, Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens, Steroids, 56, 446, 10.1016/0039-128X(91)90034-S Zhang, 2003, Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells, Cancer, 98, 2511, 10.1002/cncr.11844 Matsuzaki, 2004, Indole-3-carbinol activates the cyclin-dependent kinase inhibitor p15(INK4b) gene, FEBS Lett., 576, 137, 10.1016/j.febslet.2004.09.002 Garcia, 2005, Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex, J. Biol. Chem., 280, 8756, 10.1074/jbc.M407957200 Cram, 2001, Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter, J. Biol. Chem., 276, 22332, 10.1074/jbc.M010539200 Rahman, 2006, Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model, Mol. Cancer Ther., 5, 2747, 10.1158/1535-7163.MCT-06-0221 Cover, 1998, Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling, J. Biol. Chem., 273, 3838, 10.1074/jbc.273.7.3838 Chinni, 2001, Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells, Oncogene, 20, 2927, 10.1038/sj.onc.1204365 Frydoonfar, 2002, Inhibition of proliferation of a colon cancer cell line by indole-3-carbinol, Colorectal Dis., 4, 205, 10.1046/j.1463-1318.2002.00346.x Rahman, 2003, Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in non-tumorigenic breast epithelial cells, Nutr. Cancer, 45, 101, 10.1207/S15327914NC4501_12 Howells, 2002, Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the non-tumorigenic HBL100 line, Mol. Cancer Ther., 1, 1161 Zheng, 2002, Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells, J. Cancer Res. Clin. Oncol., 128, 539, 10.1007/s00432-002-0373-y Nachshon-Kedmi, 2003, Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells, Food Chem. Toxicol., 41, 745, 10.1016/S0278-6915(03)00004-8 Bonnesen, 2001, Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines, Cancer Res., 61, 6120 Chen, 2001, Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium, J. Nutr., 131, 3294, 10.1093/jn/131.12.3294 Ge, 1999, Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax, Anticancer Res., 19, 3199 Rahman, 2000, Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells, Oncogene, 19, 5764, 10.1038/sj.onc.1203959 Jeon, 2003, Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP, FEBS Lett., 544, 246, 10.1016/S0014-5793(03)00473-3 Chinni, 2002, Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells, Clin. Cancer Res., 8, 1228 Takada, 2005, Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells, Blood, 106, 641, 10.1182/blood-2004-12-4589 Ashok, 2001, Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol, Nutr. Cancer, 41, 180, 10.1080/01635581.2001.9680630 Ashok, 2002, Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer, Eur. J. Cancer Prev., 11, S86 Yuan, 1999, Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer, Anticancer Res., 19, 1673 Telang, 1997, Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol, Proc. Soc. Exp. Biol. Med., 216, 246, 10.3181/00379727-216-44174 Meng, 2000, Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells, J. Nutr., 130, 2927, 10.1093/jn/130.12.2927 Meng, 2000, Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes, J. Mol. Med., 78, 155, 10.1007/s001090000088 Fan, 2006, BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells, Br. J. Cancer, 94, 407, 10.1038/sj.bjc.6602935 Sundar, 2006, Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells, Mol. Endocrinol., 20, 3070, 10.1210/me.2005-0263 Hsu, 2005, Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells, Carcinogenesis, 26, 1896, 10.1093/carcin/bgi155 Hsu, 2006, Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein, Biochem. Pharmacol., 72, 1714, 10.1016/j.bcp.2006.08.012 Chatterji, 2004, Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells, Carcinogenesis, 25, 1119, 10.1093/carcin/bgh121 Lee, 2005, Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner, Biochem. Biophys. Res. Commun., 328, 63, 10.1016/j.bbrc.2004.12.138 Rahman, 2004, Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells, Nutr. Cancer, 48, 84, 10.1207/s15327914nc4801_12 Traber, 1988, Expression of cytochrome P450b and P450e genes in small intestinal mucosa of rats following treatment with phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides, J. Biol. Chem., 263, 9449, 10.1016/S0021-9258(19)76561-2 Chen, 1996, Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells, Biochem. Pharmacol., 51, 1069, 10.1016/0006-2952(96)00060-3 Chang, 2005, 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice, Carcinogenesis, 26, 771, 10.1093/carcin/bgi018 Chen, 1998, Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane, Carcinogenesis, 19, 1631, 10.1093/carcin/19.9.1631 Rahman, 2005, Inhibition of nuclear translocation of nuclear factor-κB contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells, Cancer Res., 65, 364 Riby, 2000, Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells, Biochem. Pharmacol., 60, 167, 10.1016/S0006-2952(00)00307-5 Sun, 2004, Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro, Cell Stress Chaperones, 9, 76, 10.1379/1466-1268(2004)009<0076:ERSAAC>2.0.CO;2 Vanderlaag, 2005, Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3′-indolyl)methane (DIM) and 5,5′-dibromoDIM, Cancer Lett., 236, 198, 10.1016/j.canlet.2005.05.036 Abdelrahim, 2006, 3,3′-Diindolylmethane (DIM) and derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5, Carcinogenesis, 27, 717, 10.1093/carcin/bgi270 Leong, 2001, Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression, Carcinogenesis, 22, 1809, 10.1093/carcin/22.11.1809 Hong, 2002, Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells, Biochem. Pharmacol., 63, 1085, 10.1016/S0006-2952(02)00856-0 Hong, 2002, 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression, Carcinogenesis, 23, 1297, 10.1093/carcin/23.8.1297 Gong, 2006, 3,3′-Diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21Cip1/Waf1 expression by induction of oxidative stress in human breast cancer cells, Cancer Res., 66, 4880, 10.1158/0008-5472.CAN-05-4162 Xue, 2005, DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways, Oncogene, 24, 2343, 10.1038/sj.onc.1208434 Rahman, 2006, Gene expression profiling revealed survivin as a target of 3,3′-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells, Cancer Res., 66, 4952, 10.1158/0008-5472.CAN-05-3918 Garikapaty, 2006, 3,3′-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer, Biochem. Biophys. Res. Commun., 340, 718, 10.1016/j.bbrc.2005.12.059 Nachshon-Kedmi, 2004, Therapeutic activity of 3,3′-diindolylmethane on prostate cancer in an in vivo model, Prostate, 61, 153, 10.1002/pros.20092 Kong, 2007, Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the NF-κB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer, Cancer Res., 67, 3310, 10.1158/0008-5472.CAN-06-4277 Savino, 2006, Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane, Mol. Cancer Ther., 5, 556, 10.1158/1535-7163.MCT-05-0355 Nachshon-Kedmi, 2004, Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway, Br. J. Cancer, 91, 1358, 10.1038/sj.bjc.6602145 Kim, 2007, Activation of caspase-8 contributes to 3,3′-diindolylmethane-induced apoptosis in colon cancer cells, J. Nutr., 137, 31, 10.1093/jn/137.1.31 Gong, 2006, 3,3′-Diindolylmethane is a novel topoisomerase IIα catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells, Mol. Pharmacol., 69, 1320, 10.1124/mol.105.018978 Safe, 2003, Inhibitory aryl hydrocarbon–estrogen receptor α cross-talk and mechanisms of action, Chem. Res. Toxicol., 16, 807, 10.1021/tx034036r McDougal, 2001, Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective Ah receptor modulator, Cancer Res., 61, 3901 Safe, 2001, Selective Ah receptor modulators (SAhRMs): progress towards development of a new class of inhibitors of breast cancer growth, J. Women’s Cancer, 3, 37 Abdelrahim, 2003, Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells, Mol. Pharmacol., 63, 1373, 10.1124/mol.63.6.1373 Shilling, 2001, 3,3′-Diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout, Toxicol. Appl. Pharmacol., 170, 191, 10.1006/taap.2000.9100 Leong, 2004, Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways, Mol. Endocrinol., 18, 291, 10.1210/me.2003-0196 Pearce, 2004, Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) with estrogen receptor α, Cancer Res., 64, 2889, 10.1158/0008-5472.CAN-03-1770 Abdelrahim, 2006, 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α, Cancer Res., 66, 2459, 10.1158/0008-5472.CAN-05-3132 Liu, 2006, Aryl hydrocarbon receptor agonists directly activate estrogen receptor α in MCF-7 breast cancer cells, Biol. Chem., 387, 1209, 10.1515/BC.2006.149 Liu, 2000, The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells, J. Biol. Chem., 275, 12231, 10.1074/jbc.275.16.12231 Le, 2003, Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells, J. Biol. Chem., 278, 21136, 10.1074/jbc.M300588200 McDougal, 2000, Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane, Cancer Lett., 151, 169, 10.1016/S0304-3835(99)00406-1 McDougal, 2001, Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats, Breast Cancer Res. Treat., 66, 147, 10.1023/A:1010608000074 Qin, 2004, A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes, Mol. Cancer Therap., 3, 247 Hong, 2004, Peroxisome proliferator-activated receptor γ-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins, Endocrinology, 145, 5774, 10.1210/en.2004-0686 Chintharlapalli, 2004, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induce peroxisome proliferator-activated receptor γ-mediated growth inhibition, transactivation and differentiation markers in colon cancer cells, Cancer Res., 64, 5994, 10.1158/0008-5472.CAN-04-0399 Contractor, 2005, A novel ring-substituted diindolylmethane 1,1-bis[3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl)methane inhibits ERK activation and induces apoptosis in acute myeloid leukemia, Cancer Res., 65, 2890, 10.1158/0008-5472.CAN-04-3781 Kassouf, 2006, Inhibition of bladder tumor growth by 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes: a new class of peroxisome proliferator-activated receptor γ agonists, Cancer Res., 66, 412, 10.1158/0008-5472.CAN-05-2755 Calabro, 2005, Inhibition of tumor necrosis factor-α-induced endothelial cell activation by a new class of PPARγ agonists: an in vitro study, J. Vascular Res., 42, 509, 10.1159/000088260 Chintharlapalli, 2005, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and NAG-1, Mol. Pharmacol., 68, 1782, 10.1124/mol.105.017046 Chintharlapalli, 2006, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARγ-dependent and PPARγ-independent pathways, Mol. Cancer Ther., 5, 1362, 10.1158/1535-7163.MCT-06-0002 Lei, 2006, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and -independent pathways, Mol. Cancer Ther., 5, 2324, 10.1158/1535-7163.MCT-06-0184 Chintharlapalli, 2007, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through PPARγ-independent pathways, Mol. Pharmacol., 71, 558, 10.1124/mol.106.028696 Chintharlapalli, 2005, Activation of Nur77 by selected 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways, J. Biol. Chem., 280, 24903, 10.1074/jbc.M500107200 Cho, 2007, Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and -independent pathways, Cancer Res., 67, 674, 10.1158/0008-5472.CAN-06-2907 York, 2007, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth, Clin. Cancer Res., 13, 6743, 10.1158/1078-0432.CCR-07-0967 Vanderlaag, 2007, 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways, Breast Cancer Res. Treat. Ohkura, 1994, Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells, Biochem. Biophys. Res. Commun., 205, 1959, 10.1006/bbrc.1994.2900 Winoto, 1997, Genes involved in T-cell receptor-mediated apoptosis of thymocytes and T-cell hybridomas, Semin. Immunol., 9, 51, 10.1006/smim.1996.0053 He, 2002, Orphan nuclear receptors in T lymphocyte development, J. Leukoc. Biol., 72, 440 Cheng, 1997, Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis, EMBO J., 16, 1865, 10.1093/emboj/16.8.1865 Calnan, 1995, A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection, Immunity, 3, 273, 10.1016/1074-7613(95)90113-2 Li, 2000, Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3, Science, 289, 1159, 10.1126/science.289.5482.1159 Lin, 2004, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3, Cell, 116, 527, 10.1016/S0092-8674(04)00162-X Wu, 2002, Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells, Carcinogenesis, 23, 1583, 10.1093/carcin/23.10.1583 Holmes, 2003, Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway, Oncogene, 22, 6377, 10.1038/sj.onc.1206694 Holmes, 2003, Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR, J. Cell. Biochem., 89, 262, 10.1002/jcb.10505 Wilson, 2003, TR3/Nur77 in colon cancer cell apoptosis, Cancer Res., 63, 5401 Mu, 2003, TR3 orphan nuclear receptor mediates apoptosis through up-regulating E2F1 in human prostate cancer LNCaP cells, J. Biol. Chem., 278, 42840, 10.1074/jbc.M305594200 Weng, 2007, A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells, Cancer Res., 67, 7815, 10.1158/0008-5472.CAN-07-0794